Pharmacology and safety of the leukotriene antagonists. - Wikidata - awgldk - TriplyDB

Pharmacology and safety of the leukotriene antagonists.

Pharmacology and safety of the leukotriene antagonists.

http://www.wikidata.org/entity/Q33705502

about

The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction?Role of leukotriene antagonists and antihistamines in the treatment of allergic rhinitis.

P2860

Q35166699-D2F6C558-73EE-4D57-B20E-12A79F13DB7E Q38079750-44E17A29-BB6D-44C0-8CD6-390899CC43A3

P2860

Pharmacology and safety of the leukotriene antagonists.

http://www.wikidata.org/entity/Q33705502

description

1999 nî lūn-bûn

@nan

1999 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մարտին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Pharmacology and safety of the leukotriene antagonists.

@ast

Pharmacology and safety of the leukotriene antagonists.

@en

type

label

Pharmacology and safety of the leukotriene antagonists.

@ast

Pharmacology and safety of the leukotriene antagonists.

@en

prefLabel

Pharmacology and safety of the leukotriene antagonists.

@ast

Pharmacology and safety of the leukotriene antagonists.

@en

P1433

Q33705502-7562C961-D846-4F08-BFF6-4B3BD8D5C38F

P1476

Q33705502-C59BAEBB-9403-48ED-B3EF-E4152D0B2908

P2093

Q33705502-59A9C259-D4A2-4F84-92DA-A6B3A1D8797E

P2860

Q33705502-2A39D7B3-3E54-40CC-9F6B-9E04A9ACF174

Q33705502-54015E8F-E5A3-44B1-B6C9-CAB103BCA0D4

Q33705502-6D6AD4E8-D5D6-4954-912F-63A63233A27B

Q33705502-7479FED6-5114-4B7F-918B-D4CB10488F03

Q33705502-87DF1D9F-195D-4786-9D91-9784A1107B29

Q33705502-93FFEBEC-FDF2-4353-A33E-B8D65DCBB69C

Q33705502-A200C71F-B92C-4898-A342-3B15DE868BFE

Q33705502-A88DA781-9969-49A0-9B9C-1A572D5A2145

Q33705502-AE958829-F1C8-4F03-8EFD-859C74114CE9

Q33705502-C867A071-01FF-46C9-8475-62170F123F3B

P2888

Q33705502-3D0D48B7-4ABE-4419-B8BF-FD4B047F742E

P304

Q33705502-E887A330-F9B7-47EB-A6A2-8C1953E108EE

P31

Q33705502-FF5696D9-D2F8-418A-96E3-3C8E9966A076

P356

Q33705502-9B130992-35F4-47F1-84B1-4618CFE287AD

P433

Q33705502-367525F4-076B-4F60-AA27-B8E8CBD7591D

P478

Q33705502-98F16CF8-A9F5-4DD6-87BB-3B7DE07C966C

P577

Q33705502-18C52983-AB89-483A-B6A5-07908B0FC782

P6179

Q33705502-04D77CF7-619F-4BC5-A4CD-D6CB6EFD281A

P698

Q33705502-2FE141B6-559D-4301-9207-4FD59994F61B

P356

P1433

Clinical Reviews in Allergy & Immunology

P1476

Pharmacology and safety of the leukotriene antagonists.

@en

P2093

Smith LJ

http://www.w3.org/2001/XMLSchema#string

P2860

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

The leukotriene receptor antagonist zafirlukast inhibits sulfur dioxide-induced bronchoconstriction in patients with asthma.

Inhibition of leukotriene D4-induced bronchoconstriction in normal subjects by the oral LTD4 receptor antagonist ICI 204,219.

L-648,051, a novel cysteinyl-leukotriene antagonist is active by the inhaled route in man.

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group.

The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma.

Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction.

Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics.

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.

P2888

P304

195-212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF02737604

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

1999-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1023412827

http://www.w3.org/2001/XMLSchema#string

P698

10436866

http://www.w3.org/2001/XMLSchema#string